Skip to main content

Sitaxsentan Proves Effective in Pulmonary Arterial Hypertension : The phase III trial found that the 100-mg dose improved WHO functional class vs. placebo.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Sitaxsentan Proves Effective in Pulmonary Arterial Hypertension : The phase III trial found that the 100-mg dose improved WHO functional class vs. placebo.

User login

Username

Password

Reset your password

Type	Lead	score